ORAL ANTIDIABETIC THERAPY

被引:13
作者
WILLIAMS, RH
POLLEN, RH
TANNER, DC
BARNES, RH
机构
关键词
D O I
10.7326/0003-4819-51-6-1121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1121 / 1133
页数:13
相关论文
共 26 条
[2]  
IEZZONI DG, 1959, COMMUNICATION
[3]  
KIRTLEY WR, 1959, COMMUNICATION
[4]   CLINICAL TRIALS WITH DBI, A NEW NONSULFONYLUREA ORAL HYPOGLYCEMIC AGENT [J].
KRALL, LP ;
CAMERINIDAVALOS, R .
ARCHIVES OF INTERNAL MEDICINE, 1958, 102 (01) :25-31
[5]   CLINICAL EVALUATION OF FORMAMIDINYLIMINOUREA, A NEW BIGUANIDE ORAL BLOOD SUGAR LOWERING COMPOUND - COMPARISON WITH OTHER HYPOGLYCEMIC AGENTS [J].
KRALL, LP ;
BRADLEY, RF .
ANNALS OF INTERNAL MEDICINE, 1959, 50 (03) :586-613
[6]   THE MECHANISM OF ACTION OF THE SULFONYLUREAS IN DIABETES MELLITUS [J].
LEVINE, R ;
SOBEL, GW .
DIABETES, 1957, 6 (03) :263-269
[7]   DIABETES AND THE INSULIN-ADMINISTRATION PROBLEM [J].
LEWIS, JJ .
PHYSIOLOGICAL REVIEWS, 1949, 29 (01) :75-90
[9]   RESULTS OF LONG-TERM USE OF TOLBUTAMIDE (ORINASE) IN DIABETES MELLITUS [J].
MEHNERT, H ;
CAMERINIDAVALOS, R ;
MARBLE, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 167 (07) :818-827
[10]  
MIRSKY I. ARTHUR, 1958, PENNSYLVANIA MED JOUR, V61, P861